Is Fidelity Select Biotechnology a Strong Mutual Fund Pick Right Now - Yahoo Movies Canada
| FBIOX Fund | USD 20.46 0.14 0.68% |
Slightly above 62% of Biotechnology Portfolio's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Portfolio Biotechnology mutual fund suggests that many investors are alarmed at this time. Biotechnology Portfolio's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Portfolio's earnings reports, geopolitical events, and overall market trends.
Biotechnology |
Is Fidelity Select Biotechnology a Strong Mutual Fund Pick Right Now Yahoo Movies Canada
Read at news.google.com
 |
Biotechnology Portfolio Fundamental Analysis
We analyze Biotechnology Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Biotechnology Portfolio is rated # 5 fund in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Biotechnology Portfolio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics with similar companies.
Peers
Biotechnology Portfolio Related Equities
| FSMEX | Medical Equipment | 0.42 | ||||
| FBIOX | Biotechnology Portfolio | 0.68 | ||||
| FSCSX | Software | 1.25 | ||||
| FSPTX | Technology Portfolio | 1.36 | ||||
| FSELX | Fidelity Select | 2.44 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |